Divis Gregory J
- SEC CIK
- 0001410677
No open-market purchases or sales filed in the past year.
Current role at each company
- AVDL Avadel Pharmaceuticals PLCChief Executive Officeras of Feb 12, 2026
- JAGX Jaguar Health, Inc.Directoras of May 18, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Divis Gregory J as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
AVDL Avadel Pharmaceuticals PLC
Chief Executive Officer3 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 31, 2022 (view filing) | May 27 | 4 days | Divis Gregory JChief Executive Officer | PPurchaseADSs | +50.0K | $2.05 | +$102.5K | +50.5%149.1K after | |
| Aug 10, 2023 (view filing) | Aug 10 | Same day | Divis Gregory JChief Executive Officer | PPurchaseADSs | +10.0K | $13.20 | +$132.0K | +6.7%159.1K after | |
| Dec 10, 2024 (view filing) | Dec 6-9 | 4 days | Divis Gregory JChief Executive Officer | PPurchase | +10.0K | $9.97 | +$99.7K | New position10.0K after | 2 lots |